Matches in Wikidata for { <http://www.wikidata.org/entity/Q92178049> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q92178049 description "article scientifique publié en 2019" @default.
- Q92178049 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92178049 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92178049 description "scientific article published on 13 December 2019" @default.
- Q92178049 description "wetenschappelijk artikel" @default.
- Q92178049 description "наукова стаття, опублікована 13 грудня 2019" @default.
- Q92178049 name "Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab" @default.
- Q92178049 name "Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab" @default.
- Q92178049 type Item @default.
- Q92178049 label "Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab" @default.
- Q92178049 label "Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab" @default.
- Q92178049 prefLabel "Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab" @default.
- Q92178049 prefLabel "Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab" @default.
- Q92178049 P1433 Q92178049-E092AE21-469C-4DCA-A839-6D53394EE48B @default.
- Q92178049 P1476 Q92178049-7EA7C428-8332-4D76-8A2F-8AE6AD5D1A01 @default.
- Q92178049 P2093 Q92178049-0039AF53-A270-49C4-B130-93A6F4B4BAED @default.
- Q92178049 P2093 Q92178049-34F35C89-33FD-4B0E-927A-51EE700B8992 @default.
- Q92178049 P2093 Q92178049-38759DBE-4AE4-4B44-BC46-39E0FF523DF6 @default.
- Q92178049 P2093 Q92178049-6BEAE18E-8796-4E67-8E2D-4E17F131029B @default.
- Q92178049 P2093 Q92178049-9628D184-3956-48AB-ACBF-4A8F9185429A @default.
- Q92178049 P2093 Q92178049-987569FF-BC8A-4423-8408-D73A7F1C5112 @default.
- Q92178049 P2093 Q92178049-A5D03097-02D4-4EF1-8F1E-21725D17BA36 @default.
- Q92178049 P2093 Q92178049-A68FA136-F3C8-4CE0-BB63-190E4537A729 @default.
- Q92178049 P2093 Q92178049-B9E2D58B-53BA-49FB-A400-B7162F870D13 @default.
- Q92178049 P2093 Q92178049-C72DD645-17AB-493E-9D45-B1E2F09A61BD @default.
- Q92178049 P304 Q92178049-35094E1D-6840-4A58-AF6C-F9E94E743A95 @default.
- Q92178049 P31 Q92178049-0EA4F746-FBEE-460C-8ACE-695321556EFA @default.
- Q92178049 P356 Q92178049-BE49A36A-9305-4E59-BC8B-B130D365C2FE @default.
- Q92178049 P478 Q92178049-8E3E1DC8-AA33-4395-A4E6-61F862DF318B @default.
- Q92178049 P50 Q92178049-3B32D53F-A572-4C18-ADE4-9E86AD1AA358 @default.
- Q92178049 P577 Q92178049-E85231D8-F80F-4D93-AF12-F635B4651C9C @default.
- Q92178049 P698 Q92178049-FA260CF6-6D68-4B0A-AFF8-0F13ACBE7499 @default.
- Q92178049 P356 J.MSARD.2019.101893 @default.
- Q92178049 P698 31865273 @default.
- Q92178049 P1433 Q26842267 @default.
- Q92178049 P1476 "Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab" @default.
- Q92178049 P2093 "Benjamin Ettle" @default.
- Q92178049 P2093 "Christian Cornelissen" @default.
- Q92178049 P2093 "Christoph Lassek" @default.
- Q92178049 P2093 "Holger Albrecht" @default.
- Q92178049 P2093 "Judith Haas" @default.
- Q92178049 P2093 "Luisa Klotz" @default.
- Q92178049 P2093 "Michael Lang" @default.
- Q92178049 P2093 "PANGAEA Study Group" @default.
- Q92178049 P2093 "Stephan Schmidt" @default.
- Q92178049 P2093 "Tjalf Ziemssen" @default.
- Q92178049 P304 "101893" @default.
- Q92178049 P31 Q13442814 @default.
- Q92178049 P356 "10.1016/J.MSARD.2019.101893" @default.
- Q92178049 P478 "39" @default.
- Q92178049 P50 Q48239917 @default.
- Q92178049 P577 "2019-12-13T00:00:00Z" @default.
- Q92178049 P698 "31865273" @default.